comparemela.com

Page 5 - Rob Volansky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deciphering telltale signs, symptoms of non-radiographic axial SpA remains a challenge

Given the limited awareness of non-radiographic axial spondyloarthritis, differentiating this disease from radiographic disease and prescribing appropriate therapy remains a key challenge, according to a presentation at the Biologic Therapies Summit. “Epidemiological knowledge in the United States about this disease is limited,” Marina Magrey, MD, the rheumatology fellowship program

Medical research just starting to scratch the surface on cytokine storm syndrome

While COVID-19 launched cytokine storm syndrome to the forefront of medical research, there is still much to be learned about these hyperactive immune events, according to a presenter at the Biologic Therapies Summit.“A cytokine storm is an immune dysregulation that causes collateral damage,” David Fajgenbaum, MD, MBA, MSc, assistant professor at the Perelman School of Medicine at the

Therapeutic headway still lacking for rare VEXAS disease

Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio VEXAS syndrome is a recently discovered disease that features fever, orchitis, skin nodules and small- or medium-vessel vasculitis, among other symptoms, according to a presenter at the Biologic Therapies Summit. Peter Grayson, MD , head of the vasculitis translational research program and associate director of the NIAMS Fellowship Program, offered clinicians tips on recognizing this complex, clinically challenging and frequently fatal condition. “We will end by developing a clinical algorithm that will hopefully be helpful to you,” he said.

Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis

Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis Source: Warrington K. When should biologic agents be introduced in giant cell arteritis and for how long should they be given? Presented at: Biologic Therapies Summit IX; May 21-23, 2021 (virtual meeting). Disclosures: Warrington reported no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You ve successfully added to your alerts. You will receive an email when new content is published. Back to Healio

OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting

OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting Source: Quicke. The OARSI Joint Effort Initiative Repository of Online Osteoarthritis Management Programmes: An Implementation Rapid Response During COVID-19. Presented at: OARSI 2021 World Congress on Osteoarthritis; April 29-May 1. (virtual meeting). Disclosures: Quicke reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You ve successfully added to your alerts. You will receive an email when new content is published.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.